GERN FY 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$253,000-45.0% YoY

Gross Profit

-$50M-19683.4% margin

Operating Income

-$77M-30400.4% margin

Net Income

-$76M-29888.1% margin

EPS (Diluted)

$-0.28

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$67M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$271M

Total Liabilities

$60M

Stockholders' Equity

$211M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253,000	$460,000	-45.0%
Gross Profit	-$50M	-$51M	+2.0%
Operating Income	-$77M	-$73M	-6.1%
Net Income	-$76M	-$69M	-10.3%